[11C]FMAU and [18F]FHPG as PET tracers for herpes simplex virus thymidine kinase enzyme activity and human cytomegalovirus infections

Nuclear Medicine and Biology

Volumn 27, Issue 2, 2000, Pages 113-119

  De Vries, Erik F J ^a   Van Waarde, Aren ^a   Harmsen, Marco C ^a   Mulder, Nanno H ^a   Vaalburg, Willem ^a   Hospers, Geke A P ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

11C FMAU; 18F FHPG; Herpes simplex virus thymidine kinase Cytomegalovirus protein kinase UL97; Positron emission tomography

Indexed keywords

9 [4 HYDROXY 2 (HYDROXYMETHYL)BUTYL]GUANINE; CLEVUDINE; GANCICLOVIR; THYMIDINE KINASE; TRACER; 2'-FLUORO-5-METHYLARABINOSYLURACIL; 9 ((3 FLUORO 1 HYDROXY 2 PROPOXY)METHYL)GUANINE; 9-((3-FLUORO-1-HYDROXY-2-PROPOXY)METHYL)GUANINE; ANTIVIRUS AGENT; DIAGNOSTIC AGENT; DRUG DERIVATIVE; GANCICLOVIR KINASE; PHOSPHOTRANSFERASE; RADIOPHARMACEUTICAL AGENT; URACIL ARABINOSIDE;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CYTOMEGALOVIRUS INFECTION; ENZYME ACTIVITY; GENE THERAPY; HERPES SIMPLEX VIRUS; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PROTEIN EXPRESSION; RAT; SUICIDE GENE; UMBILICAL VEIN; CELL LINE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CYTOMEGALIC INCLUSION BODY DISEASE; ENZYMOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; SCINTISCANNING;

ANTIVIRAL AGENTS; ARABINOFURANOSYLURACIL; CELL LINE; CYTOMEGALOVIRUS INFECTIONS; GANCICLOVIR; HUMANS; IMMUNOHISTOCHEMISTRY; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); RADIOPHARMACEUTICALS; SIMPLEXVIRUS; THYMIDINE KINASE; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0033625201     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(99)00105-5     Document Type: Article

References (45)

1. Abbruzzese J.L., Schmidt S., Raber M.N., Levy J.K., Castellanos A.M., Legha S.S., Krakoff I.H. Phase I trail of FMAU terminated by severe neurologic toxicity. Invest. New Drug. 7:1989;195-201.
2. 18F]FHBG) A new potential imaging agent for viral infection and gene therapy using PET . Nucl. Med. Biol. 25:1998;175-180.
3. 18F]FHPG) A potential imaging agent of viral infection and gene therapy using PET . Nucl. Med. Biol. 23:1996;787-792.
4. 18F]-FHPG) in vitro and in vivo as a probe for PET imaging of gene incorporation and expression in tumors. Nucl. Med. Biol. 26:1999;371-376.
5. Beck C., Cayeux S., Lupton S.D., Doby B., Blankenstein T. The thymidine kinase/ganciclovir mediated "suicide" effect is variable in different tumor cells. Hum. Gene Ther. 6:1995;1525-1530.
6. Betts R.F. Cytomegalovirus infection in transplant patients. Prog. Med. Virol. 28:1982;44-64.
7. Cheng Y.-C., Dutschman G., Fox J.J., Watanabe K.A., Machida H. Differential activity of potential antiviral nucleoside analogs of herpes simplex virus-induced and human cellular thymidine kinases. Antimicrob. Agents Chemother. 20:1981;420-423.
8. Cheng Y.-C., Grill S.P., Dutschman G.E., Nakayama K., Bastow K.F. Metabolism of 9-(1,3-dihydroxy-2-propoxymethyl)guanine, a new anti-herpes virus compound, in herpes simplex virus-infected cells. J. Biol. Chem. 258:1983;12460-12464.
9. Chou T.-C., Kong X.-B., Fanucchi M.P., Cheng Y.-C., Takahashi K., Watanabe K.A., Fox J.J. Synthesis and biological effects of 2′-fluoro-5-ethyl-1-β-D-arabinofuranosyluracil. Antimicrob. Agents Chemother. 31:1987;1355-1358.
10. Colacino J.M., Lopez C. Efficacy and selectivity of some nucleoside analogs as anti-human cytomegalovirus agents. Antimicrob. Agents Chemother. 24:1983;505-508.
11. 11C]FMAU) A potential nucleoside analog for in vivo study of cellular proliferation with PET . Nucl. Med. Biol. 22:1995;783-789.
12. Crumpacker C.S. Ganciclovir. New Engl. J. Med. 335:1996;721-729.
13. Culver K.W., Ran Z., Wallbridge S., Ishii H., Oldfield E.H., Blaese R.M. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science. 256:1992;1550-1552.
14. Erice A. Resistance of human cytomegalovirus to antiviral drugs. Clin. Microbiol. Rev. 12:1999;286-297.
15. Fox D.S., Schleiss M.R. Sequence and transcriptional analysis of the guinea pig cytomegalovirus UL97 homolog. Virus Genes. 15:1997;255-264.
16. Gambhir S.S., Barrio J.R., Phelps M.E., Iyer M., Namavari M., Satyamuurthy N., Wu L., Green L.A., Bauer E., MacLaren D.C., Nguyen K., Berk A.J., Cherry S.R., Herschman H.R. Imaging adenoviral-directed reporter gene expression in living animals with positron emission tomography. Proc. Natl. Acad. Sci. USA. 96:1999;2333-2338.
17. Grefte A., Van der Giessen M., Van Son W. and The T. H. (1993) Circulating cytomegalovirus (CMV)-infected endothelial cells in patients with an active CMV infection. J. Infect. Dis. 167, 270-277.
18. Grefte A., Blom N., Van der Giessen M., Van Son W. and The T.H. (1993) Ultrastructural analysis of circulating cytomegalic cells in patients with active cytomegalovirus infection: Evidence for virus production and endothelial origin. J. Infect. Dis. 168, 1110-1118.
19. Haberkorn U., Khazaie K., Morr I., Altmann A., Müller M., Van Kaick G. Ganciclovir uptake in human mammary carcinoma cells expressing herpes simplex virus thymidine kinase. Nucl. Med. Biol. 25:1998;367-373.
20. He Z., He Y. S., Kim Y., Chu L., Ohmstede C., Biron K. K. and Coen D. M. (1997) The human cytomegalovirus UL97 protein kinase that autophosphorylates on serines and threonines. J. Virol. 71, 405-411.
21. Kas-Deelen A. M., Harmsen M. C., De Maar E. F., Van Son W. J. and The T. H. (1998) A sensitive method for quantifying cytomegalic endothelial cells in peripheral blood from cytomegalovirus-infected patients. Clin. Diagn. Lab. Immun. 5, 622-626.
22. Keller P.M., Fyfe J.A., Beauchamp L. Enzymatic phosphorylation of acyclic nucleoside analogs and correlations with antiherpetic activities. Biochem. Pharmacol. 30:1981;3071-3077.
23. Kulikowski T. Structure-activity relationships and conformational features of antiherpetic pyrimidine and purine nucleoside analogues. A review. Pharm. World Sci. 16:1994;127-138.
24. Littler E., Stuart A.D., Chee M.S. Human cytomegalovirus UL97 open reading frame encodes a protein that phosphorylates the antiviral nucleoside analogue ganciclovir. Nature. 358:1992;160-162.
25. Liu S.H., Grove K.L., Cheng Y.C. Unique metabolism of a novel antiviral L-nucleoside analog, FMAU, a substrate for both thymidine kinase and deoxycytidine kinase. Antimicrob. Agents Chemother. 42:1998;833-839.
26. Mahony W.B., Domin B.A., Zimmerman T.P. Ganciclovir permeation of the human erythrocyte membrane. Biochem. Pharmacol. 41:1991;263-271.
27. Michel D., Pavić I., Zimmermann A., Haupt E., Wunderlich K., Heuschmid M., Mertens T. The UL97 gene product of human cytomegalovirus is an early late protein with a nuclear localization but is not a nucleoside kinase. J. Virol. 70:1996;6340-6346.
28. 18F]fluoro-1-hydroxy-2-propoxy)methyl}guanine . Bioorg. Med. Chem. Lett. 7:1997;1879-1882.
29. 18F]fluoro-3-hydroxy-2-propoxy)methyl}guanine . J. Labelled Compd. Radiopharm. 37:1995;193-195.
30. Moolten F.L., Wells J.M. Curability of tumors bearing herpes thymidine kinase genes transfered by retroviral vectors. J. Natl. Cancer Inst. 82:1990;297-300.
31. Moolten F.L., Wells J.M., Heyman R.A., Evans R.M. Lymphoma regression induced by ganciclovir in mice bearing a herpes thymidine kinase transgene. Hum. Gene Ther. 1:1990;125-134.
32. Ram Z., Culver K.W., Oshiro E.M., Violla J.J., De Vroom H.L., Otto E., Chiang Y., McGarrity G.J., Muul L.M., Katz D., Blaese R.M., Oldfield E.H. Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells. Nat. Med. 3:1997;1354-1361.
33. Rawlinson W.D., Zeng F., Farrell H.E., Cunningham A.L., Scalzo A.A., Booth T.W., Scott G.M. The murine cytomegalovirus (MCMV) homolog of the HCMV phosphotransferase (UL97(pk)) gene. Virology. 233:1997;358-363.
34. Saito Y., Price R.W., Rottenberg D.A., Fox J.J., Su T.L., Watanabe K.A., Philips F.S. Quantitative autoradiographic mapping of herpes simplex virus encephalitis with a radiolabeled antiviral drug. Science. 217:1982;1151-1153.
35. Singhal S., Kaiser L.R. Cancer chemotherapy using suicide genes. Surg. Oncol. Clin. N. Am. 7:1998;505-536.
36. Sinzger C., Grefte A., Plachter B., Gouw A. S., The T. H. and Jahn G. (1995) Fibroblasts, epithelial cells, endothelial cells and smooth muscle cells are major targets of human cytomegalovirus infection in lung and gastrointestinal tissues. J. Gen. Virol. 76, 741-750.
37. Sinzger C., Jahn G. Human cytomegalovirus cell tropism and pathogenesis. Intervirology. 39:1996;302-319.
38. Sinzger C., Knapp J., Plachter B., Schmidt K., Jahn G. Quantification of replication of clinical cytomegalovirus isolates in cultured endothelial cells and fibroblasts by a focus expansion assay. J. Virol. Methods. 63:1997;103-112.
39. Sullivan V., Talarico C.L., Stanat S.C., Davis M., Coen D.M., Biron K.K. A protein kinase homologue controls phosphorylation of ganciclovir in human cytomegalovirus-infected cells. Nature. 358:1992;162-164.
40. Swanson R., Bergquam E., Wong S.W. Characterization of rhesus cytomegalovirus genes associated with anti-viral susceptibility. Virology. 240:1998;338-348.
41. Tjuvajev J.G., Avril N., Oku T., Sasjima T., Miyagawa T., Joshi R., Safer M., Beattie B., DiResta G., Daghighian F., Augensen F., Koutcher J., Zweit J., Humm J., Larson S.M., Finn R., Blasberg R. Imaging of herpes virus thymidine kinase gene transfer and expression by positron emission tomography. Cancer Res. 58:1998;4333-4341.
42. Van Zeijl M., Fairhurst J., Baum E.Z., Sun L., Jones T.R. The human cytomegalovirus UL97 protein is phosphorylated and a component of virions. Virology. 231:1997;72-80.
43. Watanabe K.A., Reichman U., Hirota K., Lopez C., Fox J.J. Nucleosides. 110. Synthesis and antiherpes virus activity of some 2′-fluoro-2′-deoxyarabinofuranosylpyrimidine nucleosides. J. Med. Chem. 22:1979;21-24.
44. 19F NMR study of the uptake of FMAU in erythrocytes Evidence of transport by facilitated and nonfacilitated pathways . Biochem. Pharmacol. 55:1998;1611-1619.
45. Zimmermann A., Michel D., Pavić I., Hampl W., Lüske A., Neyts J., De Clercq E., Mertens T. Phosphorylation of acyclovir, ganciclovir, penciclovir and S2242 by the cytomegalovirus UL97 protein A quantitative analysis using recombinant vaccinia viruses . Antiviral Res. 36:1997;35-42.